Vincenzo Patruno1, Eleonora Tobaldini2, Anna M Bianchi3, Martin O Mendez4, Orietta Coletti5, Giorgio Costantino2, Nicola Montano6. 1. Department of Biomedical and Clinical Sciences, University of Milan, Division of Medicine and Pathophysiology, L. Sacco Hospital, Milan, Italy; Division of Pulmonary Rehabilitation, I.M.F.R., Udine, Italy. 2. Department of Biomedical and Clinical Sciences, University of Milan, Division of Medicine and Pathophysiology, L. Sacco Hospital, Milan, Italy. 3. Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milano, Italy. 4. Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milano, Italy; Faculty of Sciences, Autonomous University of San Luis Potosi, Mexico. 5. Division of Pulmonary Rehabilitation, I.M.F.R., Udine, Italy. 6. Department of Biomedical and Clinical Sciences, University of Milan, Division of Medicine and Pathophysiology, L. Sacco Hospital, Milan, Italy. Electronic address: nicola.montano@unimi.it.
Abstract
BACKGROUND: Treatment with positive airway pressure devices improved signs and symptoms of obstructive sleep apnea syndrome (OSA); however, auto-adjusting positive pressure (APAP) device was not as effective as continuous positive airway pressure (CPAP) in reducing arterial blood pressure and insulin resistance. The role played by autonomic cardiac regulation remains to be clarified. We aimed to test the effects of CPAP and APAP on autonomic regulation and cardiorespiratory coupling during sleep. METHODS: We retrospectively analyzed full-night polysomnographic studies. 19 patients newly diagnosed with severe OSA (AHI>30) and 7 obese subjects without OSA (CON) were enrolled. Each OSA subject was assigned to CPAP or APAP treatment and underwent a sleep study after 1 week of treatment. Spectral and cross-spectral analyses of heart rate variability (HRV) and respiration were performed to assess autonomic profile and coherence (K2) between respiration and HF oscillation during sleep in CPAP, APAP and CON groups. RESULTS: In CPAP and CON, LFnu and LF/HF, markers of sympathetic modulation, decreased from N2 to N3 and increased during REM sleep (p<0.001), while in APAP group, sympathetic modulation was significantly higher compared with those of CPAP and CON during all sleep stages. K2 values were lower in APAP compared with those in CPAP and CON. CONCLUSION: APAP treatment was characterized by a greater sympathetic activation and it was associated with a lower cardio-respiratory coupling compared with CPAP. This might account for the different effects on cardiovascular risk factors induced by the two treatments.
BACKGROUND: Treatment with positive airway pressure devices improved signs and symptoms of obstructive sleep apnea syndrome (OSA); however, auto-adjusting positive pressure (APAP) device was not as effective as continuous positive airway pressure (CPAP) in reducing arterial blood pressure and insulin resistance. The role played by autonomic cardiac regulation remains to be clarified. We aimed to test the effects of CPAP and APAP on autonomic regulation and cardiorespiratory coupling during sleep. METHODS: We retrospectively analyzed full-night polysomnographic studies. 19 patients newly diagnosed with severe OSA (AHI>30) and 7 obese subjects without OSA (CON) were enrolled. Each OSA subject was assigned to CPAP or APAP treatment and underwent a sleep study after 1 week of treatment. Spectral and cross-spectral analyses of heart rate variability (HRV) and respiration were performed to assess autonomic profile and coherence (K2) between respiration and HF oscillation during sleep in CPAP, APAP and CON groups. RESULTS: In CPAP and CON, LFnu and LF/HF, markers of sympathetic modulation, decreased from N2 to N3 and increased during REM sleep (p<0.001), while in APAP group, sympathetic modulation was significantly higher compared with those of CPAP and CON during all sleep stages. K2 values were lower in APAP compared with those in CPAP and CON. CONCLUSION:APAP treatment was characterized by a greater sympathetic activation and it was associated with a lower cardio-respiratory coupling compared with CPAP. This might account for the different effects on cardiovascular risk factors induced by the two treatments.
Authors: Jose-Alberto Palma; Jorge Iriarte; Secundino Fernandez; Manuel Alegre; Miguel Valencia; Julio Artieda; Elena Urrestarazu Journal: Clin Auton Res Date: 2015-05-23 Impact factor: 4.435
Authors: Jens Spiesshoefer; Julia Aries; Alberto Giannoni; Michele Emdin; Henrik Fox; Matthias Boentert; Thomas Bitter; Olaf Oldenburg Journal: Sleep Breath Date: 2019-06-25 Impact factor: 2.816
Authors: Ramona Cabiddu; Renata Trimer; Audrey Borghi-Silva; Matteo Migliorini; Renata G Mendes; Antonio D Oliveira; Fernando S M Costa; Anna M Bianchi Journal: PLoS One Date: 2015-04-20 Impact factor: 3.240